TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to slow advanced liver cancer
Disease control Recruiting nowThis study tests whether adding a targeted drug (apatinib) and an immunotherapy (camrelizumab) to a standard liver cancer treatment (TACE) can better control cancer growth in people whose liver cancer cannot be removed by surgery. About 101 adults with intermediate or advanced li…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: PHASE3 • Sponsor: Guohui Xu • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New hope for tough lymphoma: chemo beads target large tumors
Disease control Recruiting nowThis study is for people with a type of blood cancer called diffuse large B-cell lymphoma that has come back or not responded to standard treatments. It tests a procedure called DEB-TACE, where tiny beads filled with chemotherapy are injected directly into the blood vessels feedi…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Sponsor: Ting YANG • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Mushroom extract may ease liver damage after cancer procedure
Symptom relief Recruiting nowThis study looks at whether Antrodia cinnamomea, a type of mushroom, can help people with liver cancer recover liver function and feel better after a procedure called transarterial chemoembolization (TACE). About 60 adults aged 20 to 80 with mild to moderate liver disease will ta…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Taichung Tzu Chi Hospital • Aim: Symptom relief
Last updated Apr 29, 2026 15:01 UTC